Tedor Pharma: Elevating a CDMO Brand Through a Strategic Visual Identity
Stage of Organization: Growth
Strategic Focus: GTM Strategy Development, Identity System Design, and Communications
Outcome: Strategic Alignment and Brand Design contributed to Tedor’s turnaround—supporting 60% revenue growth and an Inc. 5000 listing in 2019
Role of Chris Cureton: Led identity system and communications design while embedded as Senior Art Director at Concentric.
“Tedor Pharma Services is a science-driven CDMO … specializing in DEA-scheduled products, high potency, powder biologics, and small batch manufacturing.”
- Tedor Pharma
-
Despite FDA and DEA credentials, Tedor’s brand presence lagged behind its operational maturity:
A lack of polished design limited their ability to connect with branded pharma companies
Legacy visuals did not reflect the quality or precision of their services
Leadership saw visual identity as essential to signaling their future-readiness in the CDMO space
-
This project reflects Phase 2: Building the System in the USBD Framework.
As Art Director at Concentric, Chris Cureton led the visual design execution—interpreting a strategic brief and translating it into a new, scalable identity system for Tedor Pharma.
Objectives
Create a modern, credible logo system tailored to a regulated industry
Establish a flexible visual framework for packaging, web, and presentation use
Help differentiate Tedor as a partner for both branded and generic pharma
Key Deliverables:
Logo system (icon + wordmark), color palette, type hierarchy
Visual extensions for digital and environmental use
Identity documentation and usage guidance
-
Credibility Boost: Identity signaled FDA-registered, DEA-licensed status with clarity and confidence
Growth Enablement: The updated brand supported Tedor’s 60% revenue growth in 2019, earning the company a spot on the Inc. 5000 list
Operational Scalability: Between 2022 and 2023, Tedor doubled its number of signed projects, validating brand readiness
Efficiency Gains: Today, Tedor generates approximately $12.3M in revenue with a team of just ~31, demonstrating high output and streamlined branding impact
-
In regulated categories, visual identity is a growth lever. By translating brand strategy into a bold, trust-building design system, Chris Cureton helped reposition Tedor Pharma during a pivotal moment—supporting rapid growth, expanding credibility, and helping unlock a more competitive future.